Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Frankston
Clinical trial register · Australia

Clinical Trials in Frankston, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC21 BioNTech SE7 Eikon Therapeutics5 AstraZeneca4 Acerta Pharma BV4
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Frankston

113 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Camperdown, Chermside, Greenslopes, South Brisbane, Adelaide, Frankston, Murdoch, Nedlands
2026-12-16
Not yet open
Pfizer
Phase 3
600
Frankston
2026-10-09
Recruiting
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
222
Concord, North Ryde, Woodville South, Clayton, Epping, Frankston
2026-09
Not yet open
VelaVigo Bio Inc
Phase 1/2
260
Randwick, Wollongong, Frankston
2026-08-24
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Blacktown, Campbelltown, Frankston, Hoppers Crossing, North Tamworth, Rockhampton, Wollongong
2026-08-24
Recruiting
Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction
NCT07362446Myocardial Infarction, Reperfusion Injury, AMI, STEMI (ST Elevation MI)
Nyrada Pty Ltd
Phase 2
300
Kingswood, Liverpool, Adelaide, Epping, Frankston, Saint Albans, Nedlands, Perth
2026-07-02
Recruiting
Shanghai Henlius Biotech
Phase 1
72
North Ryde, Saint Leonards, Frankston
2026-06-30
Recruiting
GlaxoSmithKline
Phase 2
60
Westmead, Woolloongabba, Box Hill, Frankston
2026-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
310
Frenchs Forest, Woolloongabba, Frankston
2026-06-18
Recruiting
Eikon Therapeutics
Phase 2/3
750
Frenchs Forest, Waratah, Frankston, Saint Albans
2026-06-15
Recruiting
Atridia Pty Ltd.
Phase 1
15
Bowral, Sydney, Elizabeth Vale, Ballarat, Frankston
2026-05-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
450
Kogarah, Sydney, Frankston
2026-03-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
400
Frenchs Forest, Woolloongabba, Frankston
2026-03-18
Recruiting
Eikon Therapeutics
Phase 1/2
160
Saint Leonards, Waratah, Ballarat, Camperdown, Frankston
2026-01-20
Recruiting
BioNTech SE
Phase 2
105
Bedford Park, Benowa, Frankston, Melbourne, Mount Pleasant, Saint Leonards, Sunshine Coast, Sydney
2025-12-04
Recruiting
Eli Lilly and Company
Phase 3
7,140
Adelaide, Blacktown, Box Hill, Brisbane, Bruce, Camberwell, Frankston, Garran
2025-12-01
Recruiting
BioNTech SE
Phase 3
558
Darlinghurst, Adelaide, Frankston, Melbourne, Westmead
2025-10-30
Recruiting
Merck Sharp & Dohme LLC
Phase 3
675
Campbelltown, Frenchs Forest, Brisbane, South Brisbane, Frankston
2025-10-08
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Box Hill, Camperdown, Chermside, Elizabeth Vale, Frankston, Frenchs Forest, Heidelberg, Hobart
2025-09-08
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Adelaide, Box Hill, Brisbane, Burwood, Clayton, Frankston, Geelong, Greenfields
2025-09-02
Recruiting
LaNova Medicines Limited
Phase 1/2
80
Wollongong, Adelaide, Frankston
2025-08-28
Recruiting
BioNTech SE
Phase 1/2
1,438
Blacktown, Darlinghurst, Wollstonecraft, Southport, Adelaide, Frankston, Heidelberg, Melbourne
2025-08-12
Recruiting
ABL Bio, Inc.
Phase 1/2
65
Frankston
2025-08-06
Recruiting
Domain Therapeutics Australia Pty Ltd
Phase 1/2
125
North Ryde, Adelaide, Frankston, Malvern, Nedlands
2025-06-25
Recruiting
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
NCT07020221Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer, Colorectal Cancer, Solid Tumor, Adult
DrugsVS-7375·Erbitux·Cetuximab·Nab-paclitaxel
Verastem, Inc.
Phase 1/2
295
Frankston
2025-06-24
Recruiting
Eikon Therapeutics
Phase 2/3
740
Wollongong, Chermside, Bedford Park, Box Hill, Frankston
2025-05-22
Recruiting
Eikon Therapeutics
Phase 1/2
130
Frankston
2025-04-30
Recruiting
Mirati Therapeutics Inc.
Phase 3
630
Canberra, North Tamworth, Orange, Brisbane, Elizabeth Vale, Frankston, Melbourne, Traralgon
2025-04-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Sydney, Brisbane, East Melbourne, Frankston
2025-04-09
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
683
Frankston
2025-03-31
Recruiting
AstraZeneca
Phase 3
990
Coffs Harbour, Frankston, Garran, Nedlands, New Lambton, Spearwood, Wollongong, Woodville South
2025-03-25
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Blacktown, Frankston
2025-03-16
Recruiting
AbbVie
Phase 1/2
252
Blacktown, Townsville, Elizabeth Vale, Frankston
2025-03-06
Recruiting
Akeso
Phase 1
100
Blacktown, North Ryde, South Brisbane, Frankston
2025-02-24
Recruiting
BioNTech SE
Phase 3
621
Waratah, Wollongong, Cairns, Kurralta Park, Woodville, Frankston, Heidelberg, St Albans
2025-02-03
Recruiting
Shandong Suncadia Medicine Co., Ltd.
Phase 1
100
Saint Leonards, Sydney, Tugun, Adelaide, Frankston
2025-01-21
Recruiting
BioNTech SE
Phase 2/3
1,580
Adelaide, Bedford Park, Cairns, Dubbo, Frankston, Joondalup, Kurralta Park, Melbourne
2025-01-07
Recruiting
Adcendo ApS
Phase 1
210
Macquarie Park, Randwick, Bedford Park, Frankston, Malvern, Melbourne, Nedlands
2024-11-25
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Fitzroy, Frankston, Sunshine Coast, Campbelltown, Gosford, North Ryde, Concord
2024-11-22
Recruiting
Bayer
Phase 1
104
Albury, Macquarie Park, Frankston, Malvern
2024-11-08
Active, closed
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
NCT06449222Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers
DrugsEribulin·Pumitamig·Gemcitabine·Paclitaxel
BioNTech SE
Phase 2
83
Frankston, Melbourne
2024-08-26
Active, closed
BioNTech SE
Phase 2
110
Adelaide, Fitzroy, Frankston, St Leonards, Westmead
2024-08-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Macquarie University, Westmead, Brisbane, Frankston
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
220
Westmead, Brisbane, East Melbourne, Frankston, Nedlands
2024-06-20
Active, closed
Sanofi
Phase 2
185
Chermside, South Brisbane, North Adelaide, Box Hill, Fitzroy, Frankston
2024-06-20
Active, closed
Celgene
Phase 3
850
Gosford, Sydney, Westmead, Tiwi, Birtinya, Southport, Frankston, Heidelberg
2024-06-19
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Camperdown, Urraween, Frankston, Nedlands
2024-05-24
Recruiting
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
NCT06343402Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, NSCLC, KRAS G12C
DrugsBBO-10203·Pembrolizumab
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Phase 1
350
Darlinghurst, Bedford Park, Woodville South, Frankston, Melbourne, Nedlands
2024-05-22
Active, closed
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms
DrugsTucatinib·Disitamab Vedotin
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
54
Frankston, Mount Waverley, Melbourne
2024-05-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Macquarie University, Westmead, Frankston, Murdoch
2024-04-14
Recruiting
AstraZeneca
Phase 3
3,850
Blacktown, Cairns, Canberra, Chermside, Clayton, Concord, Frankston, Geelong
2024-04-12
Recruiting
Peninsula Health
Observational
15
Frankston
2024-02-05
Recruiting
A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
NCT05910827Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma
DrugsHMBD-001·Cetuximab·Docetaxel
Hummingbird Bioscience
Phase 1/2
398
Sydney, Westmead, Brisbane, Greenslopes, Adelaide, Frankston, Malvern, Perth
2024-02-05
Active, closed
Genmab
Phase 3
1,095
Camperdown, Liverpool, Melbourne, Westmead, Douglas, Herston, Woolloongabba, Frankston
2024-02-05
Active, closed
Merck Sharp & Dohme LLC
Phase 2
147
Port Macquarie, Frankston
2023-12-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Port Macquarie, Westmead, Ballarat Central, Epping, Frankston
2023-12-15
Active, closed
Kangabio AUSTRALIA LTD PTY
Phase 1
54
Benowa, Birtinya, Frankston
2023-12-13
Recruiting
Eikon Therapeutics
Phase 1/2
156
Randwick, South Brisbane, Southport, Sydney, Woolloongabba, Frankston
2023-12-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
St Leonards, Sydney, Brisbane, East Melbourne, Frankston
2023-12-06
Active, closed
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
NCT06003231Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms, Head and Neck Neoplasms
DrugDisitamab Vedotin
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
120
Camperdown, Macquarie University, Old Toongabie, Frankston, Blacktown
2023-11-14
Recruiting
Stingray Therapeutics
Phase 1
25
Randwick, Clayton, Frankston
2023-10-12
Active, closed
AstraZeneca
Phase 3
5,511
Bankstown, Bendigo, Bowral, Brighton, Clayton, Coffs Harbour, Fitzroy, Frankston
2023-10-05
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Camperdown, Westmead, Brisbane, Greenslopes, South Brisbane, Adelaide, Box Hill, Frankston
2023-09-14
Recruiting
IKS014 in Advanced Solid Tumors That Express HER2
NCT05872295Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
Iksuda Therapeutics Ltd.
Phase 1
165
Concord, Sydney, Westmead, Frankston, Melbourne, Nedlands
2023-09-14
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NCT05440851Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High
University Health Network, Toronto
Not applicable
6,250
Camperdown, Kingswood, Wollongong, Bedford Park, Darlinghurst, Bendigo, Frankston, Geelong
2023-04-30
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Adelaide, Brisbane, Concord, Frankston, Garran, Herston, Joondalup, Kotara
2023-04-11
Recruiting
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
NCT05735080Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
DrugsAbemaciclib·Fulvestrant
Incyclix Bio
Phase 1/2
150
Frankston, Parkville, South Brisbane
2023-03-28
Active, closed
Merck Sharp & Dohme LLC
Phase 3
614
Orange, Adelaide, Frankston
2023-02-06
Active, closed
Hanmi Pharmaceutical Company Limited
Phase 1
170
Adelaide, Ballarat, Clayton, Frankston
2023-01-11
Active, closed
Daiichi Sankyo
Phase 3
1,170
Adelaide, Bedford Park, Frankston, Kogarah, Wollongong, Woolloongabba
2023-01-11
Recruiting
Canadian Cancer Trials Group
Phase 2
393
Liverpool, St Leonards, Waratah, Westmead, South Brisbane, Darwin, Clayton, Frankston
2022-12-19
Active, closed
Celcuity Inc
Phase 3
701
Adelaide, Fitzroy, Frankston, Nedlands, South Brisbane, Southport, Wahroonga, Woodville
2022-12-08
Active, closed
Genmab
Phase 3
549
Camperdown, Kingswood, Douglas, Frankston, Murdoch, Perth
2022-09-20
Active, closed
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
NCT05462717Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor
DrugElironrasib
Revolution Medicines, Inc.
Phase 1
222
Sydney, Frankston, Heidelberg, Warrnambool
2022-09-19
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
60
Macquarie University, Westmead, Frankston, Nedlands
2022-08-10
Recruiting
Antengene Therapeutics Limited
Phase 1
98
Sydney, Benowa, Bedford Park, Frankston, Mount Pleasant
2022-06-07
Recruiting
ORIC Pharmaceuticals
Phase 1
275
Wahroonga, Bendigo, Frankston
2022-06-01
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
83
Gosford, Liverpool, Randwick, St Leonards, Sydney, Westmead, Southport, Frankston
2022-05-30
Active, closed
Gilead Sciences
Phase 2
193
Bowral, Darlinghurst, Kogarah, Benowa, Birtinya, Bedford Park, Windsor Gardens, Frankston
2022-05-30
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
372
Alexandria, St Leonards, Sydney, Brisbane, South Brisbane, Frankston, Elizabeth Vale
2022-05-03
Recruiting
Aulos Bioscience, Inc.
Phase 1/2
159
Miranda, Bedford Park, Clayton, Frankston, Heidelberg, Melbourne, Saint Albans
2022-04-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
460
Kingswood, Waratah, Frankston, Melbourne
2022-03-24
Active, closed
Ascendis Pharma Oncology Division A/S
Phase 1/2
320
Adelaide, Brisbane, Frankston, Southport, Toorak Gardens, Waratah
2022-01-11
Active, closed
Olema Pharmaceuticals, Inc.
Phase 1
60
Waratah, Westmead, South Brisbane, Southport, Clayton, Frankston, Geelong, Nedlands
2021-12-10
Active, closed
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)
NCT04829604HER2 Positive Metastatic Breast Cancer
DrugARX788
Ambrx, Inc.
Phase 2
72
Frankston, Geelong, Nedlands
2021-10-26
Active, closed
Loxo Oncology, Inc.
Phase 3
282
Liverpool, Wentworthville, Frankston
2021-09-23
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Adelaide, Frankston, Hobart, Melbourne, Perth
2021-09-20
Active, closed
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
NCT04956640Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Endometrial Neoplasms, Ovarian Neoplasms
DrugsOlomorasib·Erbitux·Cetuximab·Pemetrexed
Eli Lilly and Company
Phase 1/2
540
St Leonards, Sydney, Adelaide, Frankston, Nedlands
2021-07-19
Recruiting
Hoffmann-La Roche
Phase 1/2
316
Bedford Park, Frankston, Melbourne, Nedlands
2021-06-22
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Macquarie Park, Westmead, Frankston, Nedlands
2021-06-18
Active, closed
Incyte Corporation
Phase 3
899
Adelaide, Ballarat, Birtinya, Brisbane, Canberra, Clayton, Frankston, Geelong
2021-05-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Macquarie University, South Brisbane, Elizabeth Vale, Frankston
2021-04-21
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
430
Brisbane, Adelaide, Clayton, Frankston, Buderim, Nedlands
2021-04-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
St Leonards, Elizabeth Vale, Frankston, Melbourne
2021-02-25
Active, closed
Genmab
Phase 3
483
Bedford Park, Concord, Frankston, South Brisbane, Waratah, Westmead
2021-01-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
Campbelltown, Kingswood, Waratah, Southport, Frankston, Heidelberg, St Albans
2020-12-08
Active, closed
Study to Evaluate D-1553 in Subjects With Solid Tumors
NCT04585035Solid Tumor, Adult, NSCLC, CRC
DrugD-1553
InventisBio Co., Ltd
Phase 1/2
180
Blacktown, East Albury, Kogarah, Waratah, Woodville South, Fitzroy, Frankston, Malvern
2020-10-02
Recruiting
ImmVira Pharma Co. Ltd
Phase 1/2
30
Bedford Park, Frankston, Melbourne
2020-09-17
Active, closed
MedImmune LLC
Phase 1
67
Frankston, Waratah
2020-08-05
Active, closed
Epizyme, Inc.
Phase 3
599
Adelaide, Bedford Park, Clayton, Geelong, Nedlands, Frankston, Hobart, Southport
2020-06-11
Active, closed
Eli Lilly and Company
Phase 3
261
Camperdown, Waratah, Westmead, Clayton, Melbourne, Frankston
2020-02-17
Active, closed
Hoffmann-La Roche
Phase 2/3
325
Macquarie Park, Wollongong, South Brisbane, Woolloongabba, Fitzroy, Frankston
2020-01-29
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
East Albury, Tweed Heads, East Melbourne, Frankston, Geelong, Heidelberg, Perth
2019-11-13
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Blacktown, Frankston, Gateshead, Kogarah, Wahroonga, Wollongong
2019-03-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
Camperdown, Sydney, South Brisbane, Frankston, Melbourne
2018-12-27
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
South Brisbane, Bedford Park, Frankston, Melbourne, Perth
2018-05-03
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Camperdown, Frankston, Kogarah, Melbourne, Murdoch
2018-03-23
Active, closed
Acerta Pharma BV
Phase 3
635
Bedford Park, Concord, Frankston, Gosford, Heidelberg, Herston, Kogarah, Murdoch
2017-04-05
Active, closed
AbbVie
Phase 1
163
Frankston, Heidelberg
2017-02-22
Active, closed
Acerta Pharma BV
Phase 3
310
Adelaide, Box Hill, Frankston, Geelong, Gosford, Hobart, Kogarah, Murdoch
2017-02-02
Active, closed
Acerta Pharma BV
Phase 3
533
Darlinghurst, Frankston, Melbourne, St Leonards, Waratah NSW, Wollongong
2015-07-28
Active, closed
Acerta Pharma BV
Phase 3
535
Darlinghurst, Frankston, Geelong, South Brisbane, Waratah NSW, Wollongong, Woodville
2015-06-26
Active, closed
Genentech, Inc.
Phase 2
378
Frankston, Melbourne
2008-10-16
Rows per page Showing 1–113 of 113
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/frankston

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 113 of those studies with a site in Frankston.

How many clinical trials are recruiting in Frankston?

59 of the 113 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 3 have not yet opened recruitment, 51 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Frankston), 113 studies
PhaseStudiesRecruitingShare
Phase 3512045.1%
Phase 1/2221719.5%
Phase 1171115%
Phase 216514.2%
Phase 2/3433.5%
Observational221.8%
Not applicable110.9%

Most active sponsors

Lead sponsors with the most studies (Frankston)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC2111
BioNTech SE75
Eikon Therapeutics55
Acerta Pharma BV40
AstraZeneca43
Eli Lilly and Company42
Genmab30
Seagen, a wholly owned subsidiary of Pfizer31
AbbVie21
Bristol-Myers Squibb20
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.